NCT07397572 Iron Supplementation and Anemia After Sleeve Gastrectomy
| NCT ID | NCT07397572 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Iron Deficiency Anemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 66 participants |
| Start Date | 2026-01-17 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 66 participants in total. It began in 2026-01-17 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn if taking extra iron pills after weight loss surgery helps prevent low iron and anemia compared to just taking a standard multivitamin. The main question it aims to answer is: Does a specific iron supplementation plan lower the number of patients who develop iron deficiency anemia in the 6 months after sleeve gastrectomy surgery? Researchers will compare two groups of patients from different hospital units to see if the extra iron works: Patients from one unit who take a prophylactic iron supplement (Ferrodep, 60 mg per day) in addition to their standard multivitamin. Patients from another unit who take only a standard multivitamin (Centrum Silver). Participants in this study will: * Have their blood tested for iron and anemia levels before surgery, and again at 3 and 6 months after surgery, as part of their regular post-operative care. * Be asked about their health and quality of life during follow-up clinic visits. * Have their medical information from their hospital records reviewed by the study team to track their progress.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 to 65 years scheduled to undergo primary laparoscopic sleeve gastrectomy (LSG). * Capable of understanding and providing written informed consent for participation. * Able and willing to commit to the 6-month post-operative follow-up schedule at the bariatric clinic. Exclusion Criteria: * Prior history of major gastrointestinal surgery (e.g., bowel resection, gastrectomy) that could independently affect iron absorption. * Pre-existing malabsorptive conditions (e.g., inflammatory bowel disease, celiac disease). * Diagnosis of other known forms of anemia (e.g., thalassemia, vitamin B12/folate deficiency, anemia of chronic disease) that would confound the diagnosis of iron deficiency anemia (IDA). * Any condition that, in the investigator's judgment, would interfere with full participation in the study or pose a significant risk.
Contact & Investigator
Aziz
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07397572 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Iron Deficiency Anemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07397572 currently recruiting?
Yes, NCT07397572 is actively recruiting participants. Contact the research team at Ahmed-eid@kasralainy.edu.eg for enrollment information.
Where is the NCT07397572 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07397572 clinical trial?
NCT07397572 is sponsored by Cairo University. The principal investigator is Aziz at Cairo University. The trial plans to enroll 66 participants.